RELMADA THERAPEUTICS, INC. Warrant, Exercise Price, Decrease
RELMADA THERAPEUTICS, INC. (RLMD) reported Warrant, Exercise Price, Decrease of $25.52 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2022-11-10
- RELMADA THERAPEUTICS, INC. warrant, exercise price, decrease for the quarter ending 2022-03-31 was $25.52.
| Period end | Warrant, Exercise Price, Decrease 3 month | Warrant, Exercise Price, Decrease 9 month |
|---|---|---|
| 2022-03-31 | $25.52 10-Q · filed 2022-05-05 | |
| 2021-09-30 | $0.10 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |